Observational studyBMC cardiovascular disorders2019
Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease.
Observational study in BMC cardiovascular disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Testing the Effect of a Smartphone App on Hospital Admissions and Sedentary Behavior in Cardiac Rehabilitation Participants: ToDo-CR Randomized Controlled Trial.JMIR mHealth and uHealth · 2023Trial
- Sex differences in secondary preventive follow-up after coronary heart events.BMC cardiovascular disorders · 2023Trial
- Association of Troponin T measurements with long-term outcomes in patients with coronary artery disease participating in a secondary prevention trial.BMC cardiovascular disorders · 2023Trial
- Long-term hospital-based secondary prevention of coronary artery disease: a randomized controlled trial.BMC cardiovascular disorders · 2021Trial
- Retinal image-based deep learning for mild cognitive impairment detection in coronary artery disease population.Heart (British Cardiac Society) · 2025Article
- Risk factor monitoring, management and use of prevention medicines in those with a history of premature coronary heart disease.Open heart · 2025Article
- Biomarker patterns in patients with cardiogenic shock versus septic shock.International journal of cardiology. Heart & vasculature · 2024Article
- Article
- Adequacy of Fatty Acids Consumption Among Individuals in Secondary Cardiovascular Prevention.Arquivos brasileiros de cardiologia · 2024Article
- Self-reported smoking status and exhaled carbon monoxide in secondary preventive follow-up after coronary heart events: Do our patients tell the truth?Tobacco prevention & cessation · 2024Article
- Inadequate management of cardiovascular risk factors prior to admission for an acute coronary event.Journal of preventive medicine and hygiene · 2022Article
- Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs.European heart journal open · 2022Article
- Time trends in incidence, treatment, and outcome in acute myocardial infarction in Norway 2013-19.European heart journal open · 2022Article
- Coronary Artery Disease in Patients Older than 35 and Eligible for Cardiovascular Secondary Prevention: An Italian Retrospective Observational Analysis of Healthcare Administrative Databases.Journal of clinical medicine · 2021Article
- Nurses' perceptions of patient participation in the myocardial infarction pathway.Nursing open · 2020Article
- Factors influencing left ventricular ejection fraction in patients with coronary microvascular disease and obstructive coronary artery disease.BMC research notes · 2020Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with established coronary artery disease (CAD) have an increased risk of new cardiovascular events. An underuse of secondary preventive drugs has been observed, and many patients may not attain the treatment goals for secondary prevention. The aims of the present nationwide register-based cohort study were to assess the degree of risk factor control and long-term outcomes in patients < 80 years with Type 1 myocardial infarction (MI) with and without prior CAD.
methodsData concerning all patients with MI admitted to hospitals in Norway from 2013 to 2016 were retrieved from the Norwegian Myocardial Infarction Register (NORMI). Long-term mortality was obtained through linkage with the Norwegian Cause of Death Registry.
resultsIn total, 47,204 patients were registered in the NORMI from 2013 to 2016. Prior CAD was recorded in 7219 (25.2%) of the 28,607 patients < 80 years old with Type 1 MIs. On average, 3 of the 6 defined treatment targets for secondary preventive therapy were attained, and only 1% of the patients achieved all targets. Patients with MI and prior CAD had increased risk of death or new MI compared to patients without prior CAD during long-term follow-up (adjusted HR 1.6, 95% CI 1.5-1.7).
conclusionsPrior CAD was frequent in patients with acute MI. The attainment of secondary preventive treatment targets in patients with MI and prior CAD was not optimal, and the long-term outcomes were reduced compared to patients without prior CAD. Increased efforts to improve risk factor control are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.